Cytomegalovirus infection, and

Fischler B, Casswall TH, Malmborg P, Nemeth A. Ganciclovir treatment in infants with cytomegalovirus infection and cholestasis. J Pediatr Gastroenterol Nutr 2002 34(2) 154-7. 

Yuki N, Tagawa Y (1998) Acute cytomegalovirus infection and IgM and-GM2 antibody. J Neurol Sci 154 14—17. 

Complications after granulocyte transfusions occur in about 15-20% of the recipients (38), most frequently in patients given granulocytes prepared by filtration leukapheresis. The complications are predominantly severe febrile reactions, the transmission of cytomegalovirus infection, and graft-versus-host disease. Of particular importance are respiratory reactions with pulmonary edema, which mostly occur in allo-immunized recipients. Leukocjrte aggregation may be the cause, with sequestration microemboli and fluid overflow, but other causes have also been suspected. Reactions appear to be more common in patients with sepsis. 

The role of mycophenolate in the rate and severity of cjdomegalovirus infection in transplant patients has been debated (SEDA-23, 407) and is difficult to evaluate in otherwise immunosuppressed patients. Whereas there was a dose-related increase in the incidence of cytomegalovirus disease in the three pivotal trials, a later analysis did not confirm that mycophenolate mofetil is specifically associated with an increased risk of cytomegalovirus infection, and suggested that over-immunosuppression rather than mycophenolate mofetil per se was the main contributing factor (SEDA-22, 418) (27-29). 

Roberts TC, Brennan DC, Buller RS, Gaudreault-Keener M, Schnitzler MA, Sternahell KA, et al. Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipients. J Infect Dis 1998 178 626-35. 

Meyers JD, Reed EC, Shepp DH, et al. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N Engl J Med 1988 318 70-75. 

Kletzmayr J, Kreuzwieser E, Klauser R. New developments in the management of cytomegalovirus infection and disease after renal transplantation. Curr Opin Urol 2001 11 153-158. 

Van der Bij W, Speich R. Management of cytomegalovirus infection and disease after solid-organ transplantation. Clin Infect Dis 2001 33(suppl 1) S33-S37. 

Cruz-Spano L, Lima-Pereira PE, Gomes da Silva-Basso N, et al. Human cytomegalovirus infection and abortion an immunohis-tochemical study. Med Sci Monit. 2002 8 BR230-BR235. 

Cytomegalovirus infection and aplastic crisis in glucose-6-phosphate dehydrogenase deficiency. 

Humar A, St Louis P, Mazzulli T, McGeer A, Lipton J, Messner H, MacDonald KS (1999) Elevated serum cytokines are associated with cytomegalovirus infection and disease in bone marrow transplant recipients. J Infect Dis 179 484-488... 

Speir E, Yu ZX, Ferrans VJ, Huang ES. Epstein SE (1998) Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ Res 83 210-216... 

Bedel AN, Hemmelgam TS, Kohli R. Retrospective review of the inddence of cytomegalovirus infection and disease after liver transplantation in pediatric patients comparison of prophylactic oral ganddovir and oral valganddovir. Liver Tfanspl 2012 18(3) 347-54. 

---